CDRH Contemplating A New Pre-market Review Division
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is considering adding a new division within its Office of Device Evaluation to improve workload distribution, CDRH Director Jeffrey Shuren said May 5.